News

Misoprostol Dosage Chart - new release!

22.06.2017 In: FIGO news
The new FIGO 2017 misoprostol-only dosage chart has been released! An update from the widely used 2012 chart detailing recommended dosages of misoprostol when used by itself for a variety of gynecological and obstetrical indications has been revised and expanded by an expert group and is now...

IJGO impact factor soars to 2.174!

15.06.2017 In: FIGO news
FIGO's journal, the International Journal of Gynecology and Obstetrics (IJGO), has seen its impact factor soar to 2.174, its highest ever! The journal’s ranking has also increased to 36/79 journals (up from 47/80). Visit the journal online. Follow IJGO on Twitter. Visit the IJGO Facebook...

FIGO condolences: Dr Babatunde Osotimehin

06.06.2017 In: FIGO news
Professor CN Purandare, FIGO President, said: 'FIGO wishes to pass on its sincere condolences to UNFPA on the very sad passing of Dr Babatunde Osotimehin , its Executive Director. 'Dr Osotimehin was truly a great global health champion, and highly regarded for his work on sexual and...

FIGO supports International Day of the Midwife 2017

05.05.2017 In: FIGO Statements, FIGO news
Statement from the International Federation of Gynecology and Obstetrics (FIGO) on the International Day of the Midwife 2017. Please click here to view the statement.

Period tracking apps often ‘disappoint’

03.05.2017 In: Gynaecology and Technology
Smartphone apps used to track menstrual cycles are often disappointing to users, according to a new study conducted by the University of Washington (UW), US. The researchers said that many apps display a lack of accuracy, assumptions about sexual identity and partners, and “an emphasis on...

Women ‘should continue to be screened for cervical cancer after 65’

02.05.2017 In: Oncology
A new study has found that women should continue to be screened for cervical cancer after the age of 65. The study, led by Dr Mary White, chief of the Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC), Georgia, US,...

Common antibiotics linked to miscarriage risk

02.05.2017 In: Fertility
A number of antibiotics have been linked to an increased risk of miscarriage in early pregnancy, according to a new study. Conducted by the Université de Montréal, Canada, the research pointed to the commonly used medications macrolides, quinolones, tetracyclines, sulfonamides and...

Potential new ovarian cancer treatment discovered

02.05.2017 In: Oncology
New research may reveal why up to 85 per cent of women experience recurrence of high-grade serous ovarian cancer - which is the most common subtype of ovarian cancer - after treatment with the chemotherapy drug carboplatin. The research, carried out by Dr Sanaz Memarzadeh, of the Eli and Edythe...

Standard UTI testing 'doesn't diagnose all cases of infection'

28.04.2017 In: Gynaecology and Women's Health
Women who are suffering from pain when going to the toilet or who constantly feel they need to urinate are likely to have a urinary tract infection (UTI), even if tests come back negative for bacterial infection. Around a quarter of UTI cases do not show up when using standard testing, meaning...

New evidence suggests low-cost drug should become frontline response for major blood loss after childbirth

27.04.2017 In: FIGO news
More than 100,000 women globally die each year from severe bleeding after childbirth. A major trial of 20,000 women found that a low-cost drug called tranexamic acid reduced deaths due to bleeding by a third. If this treatment is used quickly, it could save the lives of thousands of new mothers...

Gene discovery could lead to chlamydia cure

27.04.2017 In: Gynaecology and Women's Health
Researchers have discovered genes that can affect how the immune system reacts to infections, which they believe could lead to development of a cure for chlamydia. The sexually transmitted disease (STD) is one of the most common in Britain and usually does not present symptoms in the early stages...

Cheap drug could save thousands from post-partum bleeding

27.04.2017 In: Gynaecology and Women's Health, Newborn Health
A widely available drug could dramatically reduce the risk of death associated with bleeding after childbirth. A new study tested 20,000 women from around the world to see if the drug tranexamic (TXA) was beneficial. It was found that death as a result of bleeding was reduced by around 31 per cent...

Thousands of cancers diagnosed in A&E after GPs miss signs

26.04.2017 In: Oncology
GPs across the UK are missing the signs of cancer, causing thousands of people to be diagnosed when they visit accident and emergency. New research from Cambridge University, University College London and Public Health England (PHE) has found that people are receiving A&E cancer diagnoses,...